PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

97 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
41.
Capristo, E.* et al.: Incidence of hypoglycemia after gastric bypass vs sleeve gastrectomy: A randomized trial. J. Clin. Endocrinol. Metab. 104, 732-733 (2019)
42.
Gerards, J.* et al.: Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion. J. Clin. Endocrinol. Metab. 104, 3192-3202 (2019)
43.
Kempe-Teufel, D. et al.: A polygenic risk score of lipolysis-increasing alleles determines visceral fat mass and proinsulin conversion. J. Clin. Endocrinol. Metab. 104, 1090-1098 (2019)
44.
Lutz, S.Z. et al.: The Gly385(388)arg polymorphism of the FGFR4 receptor regulates hepatic lipogenesis under healthy diet. J. Clin. Endocrinol. Metab. 104, 2041-2053 (2019)
45.
Then, C. et al.: Serum uromodulin is associated with but does not predict type 2 diabetes in elderly KORA F4/FF4 study participants. J. Clin. Endocrinol. Metab. 104, 3795-3802 (2019)
46.
Wildberg, C.* et al.: Plasma metabolomics to identify and stratify patients with impaired glucose tolerance. J. Clin. Endocrinol. Metab. 104, 6357-6370 (2019)
47.
Wilms, B.* et al.: Timing modulates the effect of sleep loss on glucose homeostasis. J. Clin. Endocrinol. Metab. 104, 2801-2808 (2019)
48.
Capristo, E.* et al.: Incidence of hypoglycemia after gastric bypass vs sleeve gastrectomy: A randomized trial. J. Clin. Endocrinol. Metab. 103, 2136-2146 (2018)
49.
Gerst, F. et al.: The expression of aldolase B in islets is negatively associated with insulin secretion in humans. J. Clin. Endocrinol. Metab. 103, 4373-4383 (2018)
50.
Krug, R.* ; Mohwinkel, L.* ; Drotleff, B.* ; Born, J. & Hallschmid, M.: Insulin and estrogen independently and differentially reduce macronutrient intake in healthy men. J. Clin. Endocrinol. Metab. 103, 1393-1401 (2018)
51.
Lange, T.* et al.: Comprehensive metabolic profiling reveals a lipid-rich fingerprint of free thyroxine far beyond classic parameters. J. Clin. Endocrinol. Metab. 103, 2050-2060 (2018)
52.
Pietzner, M.* et al.: Hepatic steatosis is associates with adverse molecular signatures in subjects without diabetes. J. Clin. Endocrinol. Metab. 103, 3856-3868 (2018)
53.
Popp, D.* et al.: No correlation of pancreatic fat and β-cell function in young women with and without a history of gestational diabetes. J. Clin. Endocrinol. Metab. 103, 3260-3266 (2018)
54.
Stirm, L. et al.: BMI-independent effects of gestational diabetes on human placenta. J. Clin. Endocrinol. Metab. 103, 3299-3309 (2018)
55.
‘t Hart, L.M.* et al.: Blood metabolomic measures associate with present and future glycemic control in type 2 diabetes. J. Clin. Endocrinol. Metab. 103, 4569-4579 (2018)
56.
Gar, C. et al.: Patterns of plasma glucagon dynamics do not match metabolic phenotypes in young women. J. Clin. Endocrinol. Metab. 103, 972-982 (2017)
57.
Kullmann, S. et al.: Dose-dependent effects of intranasal insulin on resting-state brain activity. J. Clin. Endocrinol. Metab. 103, 253-262 (2017)
58.
Linder, K. et al.: Gestational diabetes impairs human fetal postprandial brain activity (vol 100, pg 4029, 2015). J. Clin. Endocrinol. Metab. 102, 336-336 (2017)
59.
Hansen, J.S.* et al.: Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio. J. Clin. Endocrinol. Metab. 101, 550-560 (2016)
60.
Hansen, J.S.* et al.: Exercise-induced secretion of FGF21 and follistatin are blocked by pancreatic clamp and impaired in type 2 diabetes. J. Clin. Endocrinol. Metab. 101, 2816-2825 (2016)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... ▶▶ ▶▮